Publication | Open Access
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by <i>UGT1A1</i> Status in Patients With Locally Advanced Rectal Cancer
117
Citations
35
References
2020
Year
Adding irinotecan guided by <i>UGT1A1</i> genotype to capecitabine-based neoadjuvant chemoradiotherapy significantly increased complete tumor response in Chinese patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1